Clinical Trials Logo

Clinical Trial Summary

Demonstrate that REGENETEN is superior to standard repair techniques when surgically treating high-grade (>50%) partial-thickness tears because REGENETEN preserves more of the native tendon footprint resulting in less postoperative pain and faster recovery.


Clinical Trial Description

The objective of this study is to demonstrate arthroscopic surgical treatment of high-grade (>50%) partial-thickness tears using REGENETEN yields statistically superior patient post-operative recovery outcomes, faster return to activities of daily living, and less health care utilization versus standard surgical repair techniques. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT03734536
Study type Interventional
Source Smith & Nephew, Inc.
Contact
Status Terminated
Phase N/A
Start date December 3, 2018
Completion date September 11, 2023